Core Scientific (CORZ) is facing renewed short-selling pressure, with Ortex-reported short interest reaching a four-month high exceeding 28% of the free float. This follows a steady climb from a 21.5% trough at the start of October. Despite reporting better-than-expected Q3 results, the stock has struggled, falling 21% over the past five days as broader data center fears impacted the sector. While the stock saw some dip-buying activity on Friday, the persistent increase in short interest suggests that bears remain skeptical of the company's valuation in the current market environment.
Signal data sourced from TipRanks. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.